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A method for identifying and validating single nucleotide polymorphisms (SNPs) with high-density
oligonucleotide arrays without the need for locus-specific polymerase chain reactions (PCR) is described in this
report. Genomic DNAs were divided into subsets with complexity of ∼10 Mb by restriction enzyme digestion
and gel-based fragment size resolution, ligated to a common adaptor, and amplified with one primer in a single
PCR reaction. As a demonstration of this approach, a total of 124 SNPs were located in 190 kb of genomic
sequences distributed across the entire human genome by hybridizing to high-density variant detection arrays
(VDA). A set of independent validation experiments was conducted for these SNPs employing bead-based
affinity selection followed by hybridization of the affinity-selected SNP-containing fragments to the same VDA
that was used to identify the SNPs. A total of 98.7% (74/75) of these SNPs were confirmed using both DNA
dideoxynucleotide sequencing and the VDA methodologies. With flexible sample preparation, high-density
oligonucleotide arrays can be tailored for even larger scale genome-wide SNP discovery as well as validation.
With the completion of the first draft of human genomic
consensus sequence, there is a predicable increase in interest
concerning the types and amount of genetic diversity in the
human population. The most abundant type of variations are
single nucleotide polymorphisms (SNPs) (Collins et al. 1997).
Some of these genetic variations underpin the genetic basis
for disease susceptibility and are used in genetic studies as
markers for complex traits and diseases.
High-density variation detection arrays (VDAs) have
been successfully used for large-scale SNP screening (Chee et
al. 1996; Wang et al. 1998; Cargill et al. 1999; Hacia et al.
1999; Halushka et al. 1999). In these experiments, predeter-
mined DNA targets within the genome were amplified with
specific PCR reactions. To discover SNPs in this way, each
locus in the genome needs to be amplified individually. Al-
thoughmultiple loci can be amplified in a multiplex PCR, this
multiplexing approach is costly and labor intensive in the
development stages and difficult to scale.
In this study, high-density oligonucleotide arrays were
used to screen for SNPs from a subset of human genomic
DNA. Each subset of genomic DNAs contained a complexity
up to 10 Mb and was amplified with one primer in a single
PCR reaction. Sequence variations were screened with the
same efficiency as individually amplified targets by hybridiz-
ing the same complex genomic sample to multiple designs of
VDA. In addition, the SNP candidates were validated by using
dideoxynucleotide sequencing and by using a bead-based af-
finity method to enrich fragments that contained candidate
SNPs followed by reanalyzing these enriched fragments in a
second round of VDA analysis.
RESULTS
Genome-Wide SNP Discovery
Virtual Restriction Enzyme Digestion and Size Selection
Armed with a working knowledge of the nucleotide sequence
of the human genome, restriction enzyme digestion reactions
can be carried out in silico. A straightforward computer pro-
gram to search and “cleave” at designated restriction enzyme
recognition sequences and organize the generated fragments
according to their size was employed. Genomic sequences
were downloaded from Baylor College of Medicine Human
Genome Sequencing Center (http://www.hgsc.bcm.tmc.edu/),
Lawrence Berkeley Laboratory Human Genome Center
(http://www-hgc.lbl.gov/GenomeHome.html) (now a part of
Joint Genome Institute, Department of Energy), Stanford Hu-
man Genome Center (http://www-shgc.stanford.edu/), The
Sanger Centre (http://www.sanger.ac.uk/), The Institute for
Genome Research (http://www.tigr.org/), Washington Uni-
versity Genome Sequencing Center (http://genome.wustl.
edu/gsc), and Whitehead Institute for Biomedical Research/
MIT (http://www.genome.wi.mit.edu/).They were used as in-
put data for this computer program. Using the recognition
sequence of EcoRI (5-GAATTC-3), and defining the desired
size range of identified fragments as 244–344 bp, the program
generated a collection of sequence fragments accounting for
0.3% of the input human genome sequences (250 Mb).
Generic PCR Amplification of Complex DNA
A total of 5 µg of human genomic DNA was digested with
EcoRI and the digestion products were resolved using agarose
gel electrophoresis (Fig. 1). The DNA fragments of desired size
range were excised from the gel and purified. The purified
restriction fragments were ligated to a single adaptor. PCR
amplification with one primer that hybridized to the adaptor
sequences generated the expected fragments (Fig. 1A).
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The expected 244–344 bp amplification products were
observed after electrophoretic separation (Fig. 1A). The length
of PCR product is slightly longer than the excised fragments
because of the sequences added by the ligation of the adaptor
oligonucleotides. The fold of amplification was estimated to
be >2500 by dividing the final yield of DNA after purification
by the amount of starting template.
The concordance between the virtual and experimental
selections was revealed by the hybridization results of the
amplified subset to the VDA. To determine if any particular
EcoRI fragment was present in the amplified pool, the empiri-
cally derived sequence for each fragment was required to
achieve a 50% concordance with the predicted sequence en-
coded on the array. Thus, the fragments with accordance rate
above 50% were considered as be-
ing present and amplified from the
subset excised from the gel. Accord-
ing to these criteria, 98% of the
fragments encoded on the arrays
were successfully selected from the
total genome and amplified.
Genome-Wide SNP Screening
The nucleotide sequences of 713
EcoRI fragments of the human ge-
nome with lengths from 244 to 344
bp (total of 190 kb) were randomly
selected from all possible EcoRI frag-
ments generated by virtual restric-
tion enzyme digestion. These se-
quences were then represented
onto a set of seven arrays by the
synthesis of eight oligonucleotide
probes interrogating each base and
each strand of the 190,676 selected
bases. The same EcoRI-generated
subset was selected and amplified
for each of eight unrelated indi-
viduals. The RepeatMasker pro-
gram (A.F.A. Smit and P. Green, un-
publ.; http://repeatmasker.genome.
washington.edu/cgi-bin/RM2_req.
pl) was used to search and detect
sequences that are homologous to
repetitive sequences found in the
human genome. Approximately
33.4% of the selected 190 kb en-
coded on the array consisted of re-
peat sequences (e.g., Alus, MIRs,
LINEs, LTR elements, MERs, etc).
A total of 124 SNP candidates
across the whole genome in eight
different individuals were identi-
fied (Fig. 2). A total of 88 SNPs were
present within unique sequences
and 36 in repeat regions. Their dis-
tribution among different chromo-
somes is listed in Table 1. Their al-
lele distribution was as follows: 31
A↔G, 10 A↔T, 41 C↔T, 11 C↔G,
and 17 G↔T. The ratio of transi-
tions to transversions was close to
1.5 with the most frequent substi-
tution being C↔T. Of the 124 can-
didate SNPs that were identified, 92 were successfully ampli-
fied and used for concordance studies. Using a dideoxy-
nucleotide sequencing method, 77 of the 92 SNPs (84%) were
concordant between the two methods. Discordant SNP can-
didates were predominantly variations detected only in one
chromosome.
Hybridization of Repetitive Sequences
Generically amplified genome subsets generated by size-
selecting restriction enzyme digestion products contain sig-
nificant amounts of repetitive sequences. Because of their
higher abundance in the genome than unique sequences,
hybridization intensities of probes that are homologous to
repetitive sequences, especially Alu’s, are disproportionately
Figure 1 Schemes of (A) single nucleotide polymorphism (SNP) discovery and (B) validation. (A)
Genomic DNA was digested with EcoRI and separated by size on agarose gel. A 250–350 bp fraction
was cut from the gel, extracted, and ligated to an adaptor. The ligated DNA was amplified with one
primer that interrogated the adaptor sequence. SNPs were screened by hybridizins to VDA. (B) Des-
ignated targets were enriched from total genomic DNA by oligonucleotides bound to magnetic beads
that interrogated the SNP sites. The genomic DNA was digested with EcoRI and ligated with an
adaptor. The enriched targets were amplified with the same primer and screened similarly as in A.
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Figure 2 (see facing page for legend)
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high. Such repeat sequences increase misleading cross-
hybridization signals.
This cross-hybridization was reduced by adding unla-
beled competitive human Cot-1 fraction DNA (GIBCO-BRL).
In the presence of Cot-1 DNA, the signal intensities attribut-
able to cross-hybridization were greatly suppressed or dimin-
ished whereas those of unique sequences were little affected
(Fig. 3). By maintaining an appropriate amount of the Cot-1
DNA in the hybridization solution (see below), the intensities
of probes interrogating repetitive sequences were reduced to a
level such that no bases were called by the analysis software
for these regions. Maintaining the ratio of human Cot-1 frac-
tion to the target at 2:1 effectively suppressed the signals of
Alu homologous regions while increasing the ratio to 5:1 sup-
pressed the signals of some L1 homologous sequences. Other
sequences that are homologous to less abundant repeat ele-
ments, e.g., MER and LTR, did not cause significant cross-
hybridization and were little affected by adding Cot-1 frac-
tion.
SNP Validation with Bead-Selected Targets
In comparison to gel-based sequencing methods used to vali-
date candidate SNPs, an alternative VDA-based method was
employed (Fig. 1B). A total of 109 5-biotinylated oligonucleo-
tides of 25 bases in length were synthesized with possible
biallelic variations encoded at the 13th position. These oligo-
nucleotides were pooled according to chip designs and then
bound to streptavidin magnetic beads. The sequences selected
for the bead-bound oligonucleotides corresponded to 109 of
the 713 EcoRI restriction fragments observed during the SNP
discovery phase of the project. The 124 candidate SNPs were
identified in these 109 EcoRI fragments.
The immobilized oligonucleotides were hybridized to
the generically amplified EcoRI genome subset to select those
fragments that have the designated candidate SNPs. The bead-
selected EcoRI fragments were reamplified in a single PCR re-
action as they all had a common adaptor. The amplification
products were hybridized to the same VDA that was used to
identify the original collection of 124 candidate SNPs. Be-
cause the resulting pool of targets was significantly enriched
for the few targets, the hybridization signal was substantially
improved (Fig. 3). A total of 99 of the 124 SNPs were defini-
tively identified with high confidence, 78 concordant and 21
discordant with the initial screening. Among the 21 discor-
dant candidates, 15 occurred in repeat sequences that were
identified by RepeatMasker, nine of the 15 were from three
fragments with multiple variations. Among the 25 fragments
that were not definitively identified, eight were absent, 17
were either not called by the analysis program although the
fragments were present, or possessed signals that resulted in a
low confidence score. Reanalysis of the original VDA for all
fragments that were absent after affinity selection and hybrid-
ization indicated that these fragments possessed low hybrid-
ization signals in the region that were recognized by the af-
finity oligonucleotides.
The chip-based validation was compared to the results of
gel-based sequencing. Of the 124 candidate SNPs, 75 SNP can-
didates were analyzed by both sequencing and bead-
selection/VDA validation methods. Both the sequencing and
bead-based affinity/VDA validation methods were in agree-
ment for 74 of the 75 candidate SNPs (98.7%). Results by both
methods were in agreement concerning the identity of 64
SNPs as well as the fact that 10 of the sites did not contain
candidate SNPs. A discordant result was observed at only one
site.
DISCUSSION
Genome-Wide SNP Discovery
SNPs are the most abundant form of human genetic variation
(Cooper et al. 1985). It is estimated that there are >106 SNPs
loci in each human genome. High-density oligonucleotide ar-
rays have been used for large-scale high throughput screening
for many of these SNPs (Wang et al 1998; Cargill et al 1999;
Hacia et al 1999; Halushka et al 1999; Lindblad-Toh et al.
2000). However, as a prelude to these screening experiments,
each of the targeted genomic regions to be screened required
individual amplification. To monitor 10% of the proposed
SNPs in a copy of the human genome will require 2 105
primers. Such a sample preparation approach will be consid-
erably costly and labor intensive given that a significant num-
ber of the amplification reactions are likely to fail in the initial
attempts. As an assembled final draft of the human genome
sequence approaches, an efficient, scalable, and robust sample
preparation strategy is needed.
In this study, previously characterized human genomic
sequences were initially analyzed by computer to identify the
sites where the recognition sequence for the EcoRI restriction
enzyme occur. A virtual restriction digestion of 250 Mb of
human sequence genomic was carried out and the sequences
from 713 EcoRI fragments (190 kb ) contained within the size-
selected fragments were used to assist in the design of a SNP
screening array. After that, actual EcoRI digestion and size
selection were carried out and all the fragments present in the
size-selected fragment pool were effectively amplified with
overall amplification >2500-fold in 35 cycles of PCR. Al-
though an EcoRI digestion and size selection of the resulting
products allowed for identification of SNPs from across the
human genome, the use of additional restriction enzymes fol-
lowed by size selection would allow for greater uniform cov-
erage. In subsequent experiments, fragments with lengths up
to 1600 bp were amplified to a similar level of success using a
similar strategy (data not shown).
The observed rate of SNP discovery in these experiments
was one SNP per 1500 kb genome sequence (124 SNPs/190
kb). However, because ∼33% of the EcoRI fragment sequences
are repetitive sequences, the corrected SNP rate for unique
sequences was about one SNP per 1000 bp. Additionally, some
regions of nonrepetitive sequences were sufficiently homolo-
gous to repetitive sequences to hybridize to the human Cot-1
DNA fraction. Because of the high concentration of the Cot-1
DNA used in the experiments, non repetitive sequence re-
gions with up to five base mismatches with the repetitive
sequences, especially Alu’s, were blocked by the Cot-1 DNA.
The real SNP rate was therefore close to previous results, about
one SNP per 700 bp in a survey of eight individuals. The
estimated occurrence of SNPs in unique sequences in this
study was similar to previously reported locus-specific screen-
ing results (Wang et al. 1998). For future experiments, omis-
Figure 2 SNP screening with variant detection arrays (VDAs). (A)
The whole image of 40 pM targets hybridized with VDA. (B) An ex-
panded view of a portion of A. (C) The same region of image as in B
except that the chip was hybridized with enriched targets. (D) A
single nucleotide polymorphism (SNP) detected and confirmed by
alternative sample preparation. From top to bottom, the wild type
(base T at the center), heterozygous SNP (bases C and T at the center),
and homozygous mutation (base C at the center) are shown.
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sion of repetitive sequences from the chip design is advisable.
Given the availability of >1 106 SNPs in the National
Center for Biotechnology Information (NCBI) public data-
bases, it is perhaps timely to note that the same strategy can
be employed to genotype these newly identified SNPs. By use
of precharacterized restriction enzyme digestion and size se-
lection, a collection of hundreds of thousands of SNPs can be
included in a restriction enzyme fragment subset, interro-
gated in one high-density oligonucleotide array, and assayed
with one single-tube sample preparation.
Large-Scale Hybridization-Based SNP Validation
An alternative sample preparation has been employed to vali-
date the SNPs discovered with the same chip design. Specific
DNA fragment targets were selectively enriched from the total
pool by use of oligonucleotides bound to magnetic beads.
These affinity oligonucleotides hy-
bridize near the SNP sites. Similar
enrichment was obtained when us-
ing EcoRI-fragmented total genomic
DNA as the target in place of restric-
tion enzyme generated fragments
(data not shown).
In a single-pass experiment,
the VDA validation gave rise to a
similar rate of validation with the
gel-sequencing validation and
highly concordant results. Eighty
percent (99 out of 124) of the tested
SNP candidates were definitively
identified by hybridization valida-
tion whereas 74% (92 out of 124)
were identified by gel sequencing.
Among the 75 SNP candidates that
were definitively determined, 74
were concordant between the two
validations. The hybridization-
based validation is comparable to
the gel-sequencing but uses only
one oligonucleotide instead of two
primers in PCR amplification. Such
Table 1. Summary of SNP Screening and Validation by Gel-Based Sequencing
Chromosome
Number of
selected
fragments
Number of
SNPs
Number of
SNPs tested by
gel sequencing
Number of
SNPs confirmed by
gel sequencing
1 43 8 6 4
2 3 0 0 0
3 0 0 0 0
4 20 2 2 2
5 56 9 6 4
6 79 19 15 14
7 152 27 19 18
8 7 1 1 1
9 2 1 0 0
10 3 1 1 1
11 4 0 0 0
12 29 2 2 2
13 7 0 0 0
14 6 1 1 1
15 0 0 0 0
16 29 5 4 2
17 40 5 4 3
18 1 0 0 0
19 0 0 0 0
20 13 5 5 4
21 4 0 0 0
22 34 10 8 6
X 174 27 17 14
Y 0 0 0 0
Unknown origin 7 1 1 1
Total 713 124 92 88
Figure 3 Suppression of signals of repetitve sequences with human Cot-1 fraction. The variant
detection arrays (VDAs) were hybridized with enriched targets without adding Cot-1 (A) and with 30
ng/µL human Cot-1 fraction (B). The bright signals at the top of the image are attributable to unique
sequences that were enriched. The dark region below had little intensity because the sequences were
not enriched. The lower portion shows the cross-hybridization from repetitive sequences (A) that was
diminished by adding human Cot-1 DNA.
Dong et al.
1422 Genome Research
www.genome.org
a strategy can be used to validate the SNPs that will be gen-
erated by the SNP consortium (Marshall 1999; http://
snp.cshl.org/) as well as provide a general method to select
SNPs of choice for genotyping.
METHODS
Subset Selection and Chip Design
Available human genomic sequences were obtained from the
following databases of genome centers: Baylor College of
Medicine Human Genome Sequencing Center (http://
www.hgsc.bcm.tmc.edu/), Lawrence Berkeley Laboratory
Human Genome Center (http://www-hgc. lbl .gov/
GenomeHome.html)(now a part of Joint Genome Institute,
Department of Energy), Stanford Human Genome Center
(http://www-shgc.stanford.edu/), The Sanger Centre (http://
www.sanger.ac.uk/), The Institute for Genome Research
(http://www.tigr.org/), Washington University Genome Se-
quencing Center (http://genome.wustl.edu/gsc), and White-
head Institute for Biomedical Research/MIT(http://www.
genome.wi.mit.edu/)] in FASTA format. The version of these
sequences was as of February 1999. These sequences were ana-
lyzed for the EcoRI restriction recognition sequences and a list
of fragments was generated. The size of the fragments was
calculated and fragments of the designated size range were
output to a .txt file. The sequences were not filtered for re-
petitive sequences.
A total of 713 fragments of 244–344 bp were selected
based on their distribution among 23 chromosomes from the
output sequences. The nucleotide sequences within these
fragments were built on seven chip designs to interrogate
190,000 bp. These fragments were further divided into 244–
269 bp, 270–294 bp, 295–319 bp, and 320–344 bp ranges. The
fragments within each size range were split into two sets ac-
cording to the first base 3 to the recognition site. The 117
fragments that have an A or T base right 3 to the recognition
sites at both ends in the 244–268 bp range were put in chip
design A. Similarly, chip design B had 114 fragments that
have a C or G base right 3 to the recognition sites at both
ends in the 244–268 bp range. Design C had 103 fragments
that have an A or T base right 3 to the recognition sites at
both ends in the 270–294 bp range. Design D had 103 frag-
ments that have an A or T base right 3 to the recognition sites
at both ends in the 270–294 bp range. Design E had 95 frag-
ments that have an A or T base right 3 to the recognition sites
at both ends in the 295–319 bp range. Design F had 95 frag-
ments that have a C or G base right 3 to the recognition sites
at both ends in the 295–319 bp range. Finally, design G had
88 fragments that have an A or T base right 3 to the recog-
nition sites at both ends in the 320–344 bp range.
DNA Samples Screened
The eight unrelated individuals (five females and three males)
were chosen from Centre d’Etude du Polymorphisme Human
(CEPH) pedigrees from Amish (K104-1, -16), Venezuelan
(K884-2, -15, -16) and Utah population (K1331-12, -13) as
well as an apparently normal nonfetal tissue (NA14672). The
genomic DNA samples were either purchased (NA05963B,
NA07340A, and NA14672) or isolated from cell lines
(GM11036, GM13057, GM05961, GM05995, and GM07007)
ordered from the Coriell Cell Repository.
Size Selection and Amplification
A total of 5 µg human genomic DNA ordered from Coriell or
isolated from cell lines was digested with 50 units of EcoRI in
a final volume of 40 µL solution at 37°C overnight. The di-
gestion mixtures were mixed with 10 µL 6 loading buffer
and loaded to 2% agarose gel and separated by electrophoresis
in 1 TBE buffer at 4 V/cm. Fragments between 244–344 bp
were excised from the gel, isolated with QIAGEN gel extrac-
tion kit as per the manufacturer’s instructions, ligated to
adaptors at 16°C overnight with T4 DNA ligase, and amplified
by PCR. The adaptor (5-GAT CCG AAG GGG TTC G-3 and
5-phosphate-AAT TCG AAC CCC TTC GGA TC-3) and
primer (5-GAT CCG AAG GGG TTC GAA TT-3) were synthe-
sized by Operon. The PCR reaction contained 15 mM Tris-HCl
(pH 8.0), 10 mM KCl, 5 mM MgCl2, 200 µM dNTPs, 5 µM
primer, 1 ng ligated DNA, and 5 units of AmpliTaq Gold poly-
merase (Perkin Elmer). The PCR was performed in a PE-9600
thermocylcer (Perkin Elmer) with 35 cycles of 94°C (30 sec)→
57°C (30 sec) →72°C (2 min).
Target Fragmentation, Labeling and Hybridization,
Scanning, and Analysis
PCR products for the eight individuals were purified with
QIAGEN kits and fragmented with DNase I. In each 45 µL
reaction, 5 µg DNA were digested with 0.6 units of DNase I
(Promega) at 37°C for 15 min in 10 mM Tris-acetate (pH 7.5),
10 mM magnesium acetate, and 50 mM potassium acetate.
After inactivation of DNase I at 95°C for 15 min, the mixtures
were added 2 pmole biotin-N6-ddATP (NEN Life Science Prod-
ucts) and 45 units rTdT (GIBCO BRL), and incubated at 37°C
for 1.5 h. 80 µg-Labeled DNA samples were pooled and re-
duced to 50 µL final volume, heat-denatured by boiling for 30
min, and immediately put on ice. Denatured enzymes were
removed by centrifugation. The hybridization was carried out
in hybridization solution (3.0 M tetramethylamonium chlo-
ride, 10 mM MES, 0.01% Triton-100, 0.5 µg BSA, 0.8 µg/µl
human Cot-1 fraction) at 44°C for 40 h on a rotisserie.
Array Washing, Staining, and Scanning
The arrays were washed with 10 mM MES at pH 6.5, with 0.1
M NaCl and 0.01% Triton-100 at 44°C for 30 min, and stained
with staining solution (0.01 µg/µL streptavidin-R-
phycoerythrin conjugate in 100 mMMES at pH 6.5, with 1 M
NaCl, 2.5 µg/µL BSA and 0.01% Triton-100) at 40°C for 15
min and washed on a fluidics station (Affymetrix). The arrays
were stained by goat antistrepavidin antibody at 40°C for 30
min and stained by the staining solution before being
scanned at 3.4 micron resolution on a GALVO scanner (Wang
et al. 1998).
Data Analysis
Candidate SNPs were identified using the same algorithms
and were visually reviewed as described previously (Chee et al
1996; Wang et al. 1998). On the array, four probe sequences
were synthesized for each base position in each strand with
each one at a distinguishable feature. One feature contains
the expected base (the reference base) whereas the other three
contain a mismatch at the center of the probe sequences.
Together, these oligonucleotides test for all four possible bases
at the interrogated position. Candidate SNPs were identified
by a combination of three algorithms. The first one, base-
calling, looked for positions at which hybridization to a sub-
stitution base gives a stronger signal than the reference base.
“Accordance rate” was defined as the percentage of positions
where the reference sequence has the highest intensities. A
variant was called when a substitution base had 20% higher
intensity than the reference base in any one individual. The
second algorithm, mutant fraction, examined the reference
base and each of the substitution bases in turn and calculated
the fraction of signal present in the nonreference base. The
mutant fractions for all eight samples were clustered together
to identify possible homozygous and heterozygous individu-
als. The final algorithm, footprint detection, detected signal
loss at the reference positions surrounding a nucleotide sub-
stitution by examining all individuals. Subsequently, a re-
viewer visually inspected the candidate SNPs. An empirical
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confidence score, “certain,” “likely,” and “possible,” was as-
signed to each candidate SNP based on the reviewer’s judg-
ment. Twenty six candidates were scored as “certain” and 98
as “likely.” Only those that were called with a high-
confidence score of “certain” or “likely” were selected for vali-
dation and reported here.
Bead Enrichment of Target
We enriched 109 fragments on all chip designs with bead-
assisted SNP-specific target selection. A 25-mer oligonucleo-
tide was designed around one SNP in every fragment and
synthesized with a 5 biotin. The oligonucleotides were first
bound to streptavidin-magnetic beads pretreated with 100
mM Na2P2O7 and then hybridized to 30 ng denatured PCR
products of the genome subset or 3 µg genomic DNA (106cop-
ies). The mole ratio between the oligonucleotide and the tar-
get fragment was 10,000 : 1. The bead was hybridized to the
target in 1 B&W buffer (5 mM Tris-HCl at pH 7.5, 0.5 mM
EDTA, 2.0 M NaCl) at 50°C for 16 h on a rotisserie. The beads
were washed twice with 1 B&W buffer and transferred to a
new tube, and washed 6 times with 1 B&W buffer. The
beads were finally washed once with water. DNA fragments
were eluted in 30 µL water by incubation at 80°C for 2 min.
The targets were amplified with PCR using the same condi-
tions mentioned above. Approximately 2–3 µg purified DNA
were fragmented, labeled, and hybridized to arrays. SNPs were
called and compared to the initial results.
DNA Sequencing
We used gel-based nucleotide sequencing to confirm the ma-
jority of the identified SNPs. Primers were designed with
Primer3 (http://www.genome.wi.mit.edu/cgi-bin/primer/
primer3_www.cgi) for 106 fragments identified with the 121
SNPs classified as “certain” or “likely.” The other three frag-
ments did not have enough flanking sequences for primer
design. PCR products were obtained for 109 SNP candidates
using genomic DNA as templates for the individuals that were
classified as homozygous or heterozygous for an alternative
base. The DNA samples were outsourced to Lark Technologies,
Inc. for sequencing using dye terminator chemistry on ABI
sequencers. The sequence traces were obtained for 92 SNP
candidates (23 scored as “certain” and 69 as “likely”) and
input into the same program used for SNP detection, and
compared to the screening results by visual inspection. Sev-
enty seven of the 92 SNPs (23 “certain,” 54 “likely”) were
concordant with the initial screening results.
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